Discovery of Highly Potent Multidrug Resistance (MDR) Reversal Agents: Aminosulfonylaryl Isoxazole Derivatives

DOI QR Code

Szakacs, G.; Paterson, J. K.; Ludwig, J. A.; Booth-Genthe, C.; Gottesman, M. M. Nat. Rev. Drug Discov. 2006, 5, 219. https://doi.org/10.1038/nrd1984
Modok, S.; Mellor, H. R.; Callaghan, R. Curr. Opin. Pharmacol. 2006, 6, 350. https://doi.org/10.1002/cncr.21227
Ozben, T. FEBS Lett. 2006, 580, 2903. https://doi.org/10.1016/j.febslet.2006.02.020
Longley, D. B.; Johnston, P. G. J. Pathol. 2005, 205, 275. https://doi.org/10.1080/00397910601055107
Colabufo, N. A.; Berardi, F.; Perrone, R.; Rapposelli, S.; Digiacomo, M.; Vanni, M.; Balsamo, A. J. Med. Chem. 2008, 51, 1415. https://doi.org/10.1021/jm701267q
Xia, Y.; Min, K. H.; Lee, K. Bull. Korean Chem. Soc. 2009, 30, 43. https://doi.org/10.5012/bkcs.2009.30.1.043
Pusztai, L.; Wagner, P.; Ibrahim, N.; Rivera, E.; Theriault, R.; Booser, D.; Symmans, F. W.; Wong, F.; Blumenschein, G.; Fleming, D. R.; Rouzier, R.; Boniface, G.; Hortobagyi, G. N. Cancer 2005, 104, 682. https://doi.org/10.1002/cncr.21227
Zhang, R.; Lei, L.; Xu, Y. G.; Hua, W. Y.; Gong, G. Q. Bioorg. Med. Chem. Lett. 2007, 2430.
Kurangi, R. F.; Kawthankar, R.; Sawal, S.; Desai, V. G.; Tilve, S. G. Synth. Commun. 2007, 37, 585. https://doi.org/10.1080/00397910601055107
Tsuruo, T.; Iida, H.; Tsukagoshi, S.; Sakurai, Y. Cancer Res. 1981, 41, 1967.

ChemInform Abstract: Discovery of Highly Potent Multidrug Resistance (MDR) Reversal Agents: Aminosulfonylaryl Isoxazole Derivatives. vol.40, pp.36, 2009, https://doi.org/10.1002/chin.200936122
Synthesis of 1,2,3-Triazole Substituted IsoxazolesviaCopper (I) Catalyzed Cycloaddition : Synthesis of 1,2,3-Triazole Substituted IsoxazolesviaCopper (I) Catalyzed Cycloaddition vol.49, pp.3, 2009, https://doi.org/10.1002/jhet.837
Synthesis and Biological Activity of Benzopyranyl Urea and Benzopyranyl Thiourea Derivatives as MDR Reversal Agents vol.33, pp.11, 2009, https://doi.org/10.5012/bkcs.2012.33.11.3857